semaglutide new york times A Game Changer': Drug Brings Weight Loss in Patients With Obesity — Its not your fault Compounded Semaglutide: What to Know

Since 1957 when IGF-1 and IGF-2 were identified and first designated as sulfation factors (156), the interest in the study of these molecules that structurally resembled proinsulin increased, especially when IGF-1 was found to be the mediator of the anabolic and mitogenic activity of GH (157)

By stimulating growth hormone production, the bodys metabolism improves, helping to break down fat more efficiently

Moreover, the administration of these peptides to healthy individuals for anti-aging or performance enhancement introduces additional ethical and safety considerations, as the long-term effects of chronic exposure in otherwise healthy populations remain unknown

(2025, November 21)